Nitrofurazone and Type 2 diabetes - a phase IV clinical study of FDA data

Summary:

Type 2 diabetes is reported as a side effect among people who take Nitrofurazone (nitrofurazone), especially for people who are female, 40-49 old, also take Cimzia, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Type 2 diabetes when taking Nitrofurazone. It is created by eHealthMe based on reports of 89 people who have side effects when taking Nitrofurazone from the FDA, and is updated regularly.

What is Nitrofurazone?

Nitrofurazone has active ingredients of nitrofurazone. eHealthMe is studying from 95 Nitrofurazone users. Check the latest studies of Nitrofurazone.

What is Type 2 diabetes?

Type 2 diabetes is found to be associated with 1,432 drugs and 2,347 conditions by eHealthMe. Check the latest studies of Type 2 diabetes.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

89 people reported to have side effects when taking Nitrofurazone.
Among them, 29 people (32.58%) have Type 2 diabetes.

Could Nitrofurazone cause Type 2 diabetes?

Among these 29 people:

What is the gender of people who have Type 2 diabetes when taking Nitrofurazone? *

female: 100 %
male: 0.0 %

What is the age of people who have Type 2 diabetes when taking Nitrofurazone? *

What are other drugs people take besides Nitrofurazone? *

What are other side effects people have besides Type 2 diabetes? *

Nausea And Vomiting: 28 people, 96.55%
Hair Loss: 28 people, 96.55%
Headache (pain in head): 28 people, 96.55%
High Blood Cholesterol: 28 people, 96.55%
High Blood Pressure: 28 people, 96.55%
Infusion Related Reaction: 28 people, 96.55%
Mobility Decreased (ability to move is reduced): 27 people, 93.10%
Fatigue (feeling of tiredness): 27 people, 93.10%
General Physical Health Deterioration (weak health status): 27 people, 93.10%
Hepatic Enzyme Increased: 27 people, 93.10%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 23 people, 79.31%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 22 people, 75.86%
Indigestion: 18 people, 62.07%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 13 people, 44.83%
Psoriasis (immune-mediated disease that affects the skin): 9 people, 31.03%
Fibromyalgia (a long-term condition which causes pain all over the body): 9 people, 31.03%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 8 people, 27.59%
Headache (pain in head): 8 people, 27.59%
Nausea And Vomiting: 3 people, 10.34%
High Blood Pressure: 3 people, 10.34%

* Approximation only. Some reports may have incomplete information.

Do you take Nitrofurazone and have Type 2 diabetes?

- Check whether Type 2 diabetes is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Nitrofurazone:

Nitrofurazone (95 reports)

Type 2 diabetes treatments and more:

Type 2 diabetes (391,583 reports)

Browse all side effects of Nitrofurazone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Type 2 diabetes:

Type 2 diabetes (1,432 drugs)

Browse all the conditions that are associated with Type 2 diabetes:

Type 2 diabetes (2,347 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on nitrofurazone (the active ingredients of Nitrofurazone) and Nitrofurazone (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.